Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Cystic fibrosis]

K Yoshimura¹, C Anzai

¹Department of Gene Therapy, Institute of DNA Medicine, The Jikei University School of Medicine, Japan.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|March 1, 1996

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Establishment of Namalva cell lines which grow continuously in glutamine-free medium.

Cytotechnology·2012

Same author

Static QCD potential at three-loop order.

Physical review letters·2010

Same author

Detection of measles virus genome in bronchoalveolar lavage cells in a patient with measles pneumonia.

The European respiratory journal·2000

Same author

Heterotopic gastric mucosa in a gallbladder with an anomalous union of the pancreatobiliary duct: a case report.

Hepato-gastroenterology·1998

Same author

A case of poliomyelitis-like syndrome.

Brain & development·1998

Same author

Mechanosensitive channels in the cell body of Chlamydomonas.

The Journal of membrane biology·1998

Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019

Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019

See all related articles

Cystic fibrosis (CF) is a genetic disorder caused by CFTR gene mutations. Research is exploring gene therapy and protein replacement to treat this condition.

Area of Science:

Genetics and Molecular Biology
Cellular Physiology

Context:

Cystic fibrosis (CF) is the most prevalent fatal hereditary disorder in Caucasian populations.
It stems from mutations in the CF transmembrane conductance regulator (CFTR) gene.
Over 400 distinct CFTR gene mutations have been identified, with DeltaF508 being the most common.

Purpose:

To provide an overview of the genetic basis of cystic fibrosis.
To highlight the function of the CFTR protein as a chloride channel.
To discuss emerging therapeutic strategies for CF treatment.

Summary:

The CFTR gene encodes a cyclic-AMP-regulated chloride channel protein crucial for cellular function.
This protein's activity is modulated by protein kinase phosphorylation and ATP binding.

Related Experiment Videos

The DeltaF508 mutation accounts for the majority of CF cases, but numerous other mutations exist.

Impact:

Understanding CFTR gene mutations is vital for diagnosing and managing cystic fibrosis.
New therapeutic avenues like gene therapy and protein replacement offer potential for treating CF.
Advancements in CFTR research may lead to improved patient outcomes and novel treatment modalities.